• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS FT4 II ASSAY; RADIOIMMUNOASSAY, FREE THYROXINE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS FT4 II ASSAY; RADIOIMMUNOASSAY, FREE THYROXINE Back to Search Results
Catalog Number 07027397190
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 12/19/2017
Event Type  malfunction  
Manufacturer Narrative
(b)(4).(b)(6).
 
Event Description
The customer received questionable thyroid results for two patient samples from a cobas 8000 e801 module.The serial number was requested but was not provided.Samples from the patients were submitted for investigation and were tested on a cobas 8000 e801 module, cobas 8000 e602 module, a cobas e 411 immunoassay analyzer, and a siemens centaur analyzer.Information concerning if any erroneous results was reported outside of the laboratory was requested but was unknown.There was no allegation of an adverse event.Refer to the medwatchs with (b)(6) for this event.
 
Manufacturer Narrative
As no sample material was available for investigation, a specific root cause could not be determined.From the data provided, a general reagent issue could most likely be excluded.A possible cause could be that a factor which interferes with one or more components within the assay of both roche and /or siemens is present in the samples of these patients.
 
Manufacturer Narrative
Sample from the patient was submitted for investigation.Investigation confirmed the presence of a streptavidin interfering factor.This interference is documented in product labeling for the assay: "in rare cases, interference due to extremely high titers of antibodies to analyte-specific antibodies, streptavidin or ruthenium can occur.These effects are minimized by suitable test design.For diagnostic purposes, the results should always be assessed in conjunction with the patient¿s medical history, clinical examination and other findings.The incidence rate of the identified interfering factor is monitored on a quarterly basis.A product problem was not found.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS FT4 II ASSAY
Type of Device
RADIOIMMUNOASSAY, FREE THYROXINE
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key7215205
MDR Text Key98295756
Report Number1823260-2018-00214
Device Sequence Number1
Product Code CEC
Combination Product (y/n)N
PMA/PMN Number
K131244
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup,Followup
Report Date 06/26/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number07027397190
Device Lot NumberASKU
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 01/10/2018
Initial Date FDA Received01/24/2018
Supplement Dates Manufacturer Received01/10/2018
01/10/2018
Supplement Dates FDA Received01/30/2018
06/26/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-